Supplementary Tables from LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion

Authors:
  • XZXiu-Hui Zhan
    Xiu-Hui Zhan
  • JJJi-Wei Jiao
    Ji-Wei Jiao
  • HZHai-Feng Zhang
    Hai-Feng Zhang
  • XXXiu-E Xu
    Xiu-E Xu
  • JHJian-Zhong He
    Jian-Zhong He
  • RLRun-Liu Li
    Run-Liu Li
  • HZHai-Ying Zou
    Hai-Ying Zou
  • ZWZhi-Yong Wu
    Zhi-Yong Wu
  • SWShao-Hong Wang
    Shao-Hong Wang
  • JWJian-Yi Wu
    Jian-Yi Wu
  • LLLian-Di Liao
    Lian-Di Liao
  • JWJuan-Juan Wang
    Juan-Juan Wang

Abstract
Supplementary Table S1-S4. Table S1. Correlation between expression of LOXL2 or its spliced isoform L2Δ13 and clinicopathological characteristics in ESCC patients of cohort 1 (n = 252). Table S2. Patient demographics and clinical characteristics for tissue microarray cohort 2 in ESCC (n = 135). Table S3. Multivariate Cox regression for overall survival and disease-free survival of ESCC patients (n = 252). Table S4. Interacting proteins associated with LOXL2 and L2Δ13 in KYSE150 ESCC cells identified by high-performance liquid chromatography followed by tandem mass spectrometry (LC-MS/MS) analysis.